Because G protein-coupled receptors share common pathways for the processes of desensitization and resensitization ( 36 ), the capacity to be modulated by inhibitors in this way may not be unique to CCR5, and it is possible that inhibitors that act like PSC-RANTES could be found for other therapeutically important receptors.